Graves’ Thyrotoxicosis-Induced Reversible Cardiomyopathy: A Case Report
Author(s) -
Ahmad Saeed A. Alghamdi,
Naji Aljohani
Publication year - 2013
Publication title -
clinical medicine insights case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.187
H-Index - 12
ISSN - 1179-5476
DOI - 10.4137/ccrep.s10534
Subject(s) - medicine , ejection fraction , cardiology , cardiomyopathy , heart failure , graves' disease , dilated cardiomyopathy , thyroid
The objective of this report is to present a case of Graves' thyrotoxicosis-induced cardiomyopathy. This is a case of a 26 year old woman that presented with severe symptomatic congestive heart failure and was subsequently diagnosed with dilated cardiomyopathy secondary to Graves' disease. Despite an initial left ventricular systolic ejection fraction of 20% on echocardiography, treatment with anti-thyroid agents led to rapid improvement of her clinical status and normalization of her ejection fraction. The proposed mechanisms underlying the development of systolic dysfunction in thyrotoxicosis are discussed and the literature on similar cases previously reported is highlighted. Cardiomyopathy should be considered even in young patients with Graves' thyrotoxicosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom